Hysbysiad dyfarnu contract
Canlyniadau'r weithdrefn gaffael
Adran I:
Endid
contractio
I.1) Enw a chyfeiriad
HUMBER TEACHING NHS FOUNDATION TRUST
RV9
Trust HQ, Willerby Hill, Beverley Road, Willerby
Hull
HU106ED
UK
Person cyswllt: Charlene Reeson
E-bost: c.reeson@nhs.net
NUTS: UKE12
Cyfeiriad(au) rhyngrwyd
Prif gyfeiriad: https://www.humber.nhs.uk/
I.4) Y math o awdurdod contractio
Corff a lywodraethir gan gyfraith gyhoeddus
I.5) Prif weithgaredd
Iechyd
Adran II: Gwrthrych
II.1) Cwmpas y caffaeliad
II.1.1) Teitl
Chronic Fatigue Services - Physiotherapy
II.1.2) Prif god CPV
85142100
II.1.3) Y math o gontract
Gwasanaethau
II.1.4) Disgrifiad byr
To provide physiotherapy services.
II.1.6) Gwybodaeth am lotiau
Mae’r contract hwn wedi’i rannu’n lotiau:
Na
II.1.7) Cyfanswm gwerth y caffaeliad
Gwerth heb gynnwys TAW: 20 000.00 GBP
II.2) Disgrifiad
II.2.3) Man cyflawni
Cod NUTS:
UKE
II.2.4) Disgrifiad o’r caffaeliad
To provide Physiotherapy Services for Chronic Fatigue.
We are intending to award a contract to an existing provider following direct award process C.
Approximate lifetime value of the contract is £20,000 (£10,000) pa.
The dates in which the services are intended to be provided are 22/10/2025-21/10/2027
II.2.5) Meini prawf dyfarnu
Maen prawf cost: the existing provider is satisfying the original contract and will likely satisfy the proposed contract to a sufficient standard
/ Pwysoliad: 100
II.2.11) Gwybodaeth am opsiynau
Opsiynau:
Ydy
Disgrifiad o’r opsiynau:
One 12 month period.
II.2.13) Gwybodaeth am Gronfeydd yr Undeb Ewropeaidd
Mae'r broses gaffael yn gysylltiedig â phrosiect a/neu raglen a ariennir gan gronfeydd yr Undeb Ewropeaidd:
Na
Section IV: Gweithdrefn
IV.1) Disgrifiad
IV.1.1) Y math o weithdrefn
Dyfarnu contract heb gyhoeddi galwad am gystadleuaeth yng Nghyfnodolyn Swyddogol yr Undeb Ewropeaidd ymlaen llaw
Cyfiawnhau'r weithdrefn ddyfarnu a ddewiswyd:
Mae’r caffaeliad y tu allan i gwmpas cymhwysiad y gyfarwyddeb
Esboniad
This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The publication of this notice marks the start of the standstill period. Representations by providers must be made to the relevant authority by 21/10/2025. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR'.
IV.1.8) Gwybodaeth am Gytundeb Caffael y Llywodraeth (GPA)
The procurement is covered by the Government Procurement Agreement:
Na
Section V: Dyfarnu contract
Dyfernir contract/lot:
Ydy
V.2 Dyfarnu contract
V.2.1) Y dyddiad y daeth y contract i ben
09/10/2025
V.2.2) Gwybodaeth am dendrau
Nifer y tendrau a ddaeth i law: 1
Dyfarnwyd y contract i gr?p o weithredwyr economaidd:
Na
V.2.3) Enw a chyfeiriad y contractwr
Wolds Holistic Womens Health
232827102
Driffield
UK
NUTS: UKE
BBaCh yw’r contractwr:
Ydy
V.2.4) Gwybodaeth am werth y contract/lot (heb gynnwys VAT)
Amcangyfrif cychwynnol o gyfanswm gwerth y contract/lot: 20 000.00 GBP
Cyfanswm gwerth y contract/lot: 20 000.00 GBP
V.2.5) Gwybodaeth am is-gontractio
Section VI: Gwybodaeth ategol
VI.3) Gwybodaeth ychwanegol
This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The publication of this notice marks the start of the standstill period. Representations by providers must be made to decision makers by 21/10/2025.
This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR.'
Written representations should be sent to: Phillip.simmons@nhs.net
Details of the award decision-makers; are Marie Acton and Adrian Elsworth
Any declared or potential conflicts of interest were managed as per the Trusts policy.
The relative importance of the key criteria was measured by pass and fail.
VI.4) Gweithdrefnau adolygu
VI.4.1) Corff adolygu
The Independent Patient Choice and Procurement Panel
London
UK
VI.5) Dyddiad anfon yr hysbysiad hwn
09/10/2025